title: Vesicular and bullous disorders: pemphigus.
abstract: Pemphigus is a chronic, autoimmune disease involving the skin and Malpighian mucous membranes. Pemphigus leads to progressive blistering and subsequent erosions. This article describes the etiology and treatment of pemphigus.
authors: Department of Dermatology, Second University of Naples, Via Sergio Pansini 5, 80131-Naples, Italy.
authors: Adone
authors: A
authors: Baroni
authors: Alessandro
authors: A
authors: Lanza
authors: Nicola
authors: N
authors: Cirillo
authors: Giampiero
authors: G
authors: Brunetti
authors: Eleonora
authors: E
authors: Ruocco
authors: Vincenzo
authors: V
authors: Ruocco
mesh_terms: D001323:Autoantibodies / Q000502:physiology*; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D051183:Desmoglein 1 / Q000276:immunology; D051184:Desmoglein 3 / Q000276:immunology; D006801:Humans; D007159:Immunologic Tests; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D012867:Skin / Q000276:immunology / Q000503:physiopathology*
chemical_list: D001323:Autoantibodies; D018680:Cholinergic Antagonists; C495297:DSG1 protein, human; C071894:DSG3 protein, human; D051183:Desmoglein 1; D051184:Desmoglein 3; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic